The role of serotonergic, adrenergic and dopaminergic receptors in antidepressant-like effect

[1]  B. Czéh,et al.  Animal models of major depression and their clinical implications , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  Ricieri Mocelin,et al.  Involvement of the catecholaminergic system on the antidepressant-like effects of Alpinia zerumbet in mice , 2016, Pharmaceutical biology.

[3]  A. Gałuszka,et al.  The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation. , 2015, European journal of pharmacology.

[4]  M. Kołaczkowski,et al.  Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats , 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.

[5]  S. Sadigh-Eteghad,et al.  Antidepressant-like effect of modafinil in mice: Evidence for the involvement of the dopaminergic neurotransmission , 2015, Pharmacological reports : PR.

[6]  Silvia Laura Guzmán-Gutiérrez,et al.  Linalool and β-pinene exert their antidepressant-like activity through the monoaminergic pathway. , 2015, Life sciences.

[7]  A. Landau,et al.  α2-adrenoceptor binding in Flinders-sensitive line compared with Flinders-resistant line and Sprague-Dawley rats , 2015, Acta Neuropsychiatrica.

[8]  R. Felder,et al.  The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease. , 2015, Translational research : the journal of laboratory and clinical medicine.

[9]  S. Z. Langer.  α2-Adrenoceptors in the treatment of major neuropsychiatric disorders. , 2015, Trends in pharmacological sciences.

[10]  A. Landau,et al.  Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depression , 2015, Neuropharmacology.

[11]  A. Pupo,et al.  Involvement of α1B-adrenoceptors in the anti-immobility effect of imipramine in the tail suspension test. , 2015, European journal of pharmacology.

[12]  Yixing Gao,et al.  Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test , 2015, Behavioural Brain Research.

[13]  A. Waszkielewicz,et al.  Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: The involvement of serotonergic system , 2015, Pharmacological reports : PR.

[14]  I. Ishola,et al.  Potential of novel phytoecdysteroids isolated from Vitex doniana in the treatment depression: Involvement of monoaminergic systems , 2014, Pharmacology Biochemistry and Behavior.

[15]  L. Savegnago,et al.  Antidepressant-like activity of dehydrozingerone: Involvement of the serotonergic and noradrenergic systems , 2014, Pharmacology Biochemistry and Behavior.

[16]  D. Macêdo,et al.  Antidepressant-like effect of Hoodia gordonii in a forced swimming test in mice: evidence for involvement of the monoaminergic system , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[17]  J. Stehberg,et al.  Dopamine receptor D3 deficiency results in chronic depression and anxiety , 2014, Behavioural Brain Research.

[18]  G. Turecki.  The molecular bases of the suicidal brain , 2014, Nature Reviews Neuroscience.

[19]  G. Zeni,et al.  The antidepressant-like effect of 7-fluoro-1,3-diphenylisoquinoline-1-amine in the mouse forced swimming test is mediated by serotonergic and dopaminergic systems , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  J. García-Sevilla,et al.  Increased α2- and β1-adrenoceptor densities in postmortem brain of subjects with depression: differential effect of antidepressant treatment. , 2014, Journal of affective disorders.

[21]  S. Bhatt,et al.  Neuropharmacological effect of novel 5-HT_3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences , 2014, Pharmacological reports : PR.

[22]  S. Bhatt,et al.  Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations , 2014, Pharmacology Biochemistry and Behavior.

[23]  S. Bhatt,et al.  Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice , 2014, Indian journal of pharmacology.

[24]  H. Pertz,et al.  α2-Adrenoceptors are targets for antipsychotic drugs , 2014, Psychopharmacology.

[25]  D. Macêdo,et al.  Involvement of monoaminergic system in the antidepressant‐like effect of riparin I from Aniba riparia (Nees) Mez (Lauraceae) in mice , 2014, Fundamental & clinical pharmacology.

[26]  S. Salomone,et al.  Dopamine D(3) receptor as a new pharmacological target for the treatment of depression. , 2013, European journal of pharmacology.

[27]  C. López-Rubalcava,et al.  The antidepressant-like effect of ethynyl estradiol is mediated by both serotonergic and noradrenergic systems in the forced swimming test , 2013, Neuroscience.

[28]  D. Macêdo,et al.  Antidepressant‐like effect of bis‐eugenol in the mice forced swimming test: evidence for the involvement of the monoaminergic system , 2013, Fundamental & clinical pharmacology.

[29]  A. Piotrowska,et al.  Involvement of the monoaminergic system in the antidepressant-like activity of chromium chloride in the forced swim test. , 2013, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[30]  C. Mathias,et al.  Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System , 2013 .

[31]  A. Rodrigues,et al.  The activation of α1-adrenoceptors is implicated in the antidepressant-like effect of creatine in the tail suspension test , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  P. Liu,et al.  Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice , 2013, Behavioural Brain Research.

[33]  K. Tan-No,et al.  Chronic fluvoxamine treatment changes 5-HT(2A/2C) receptor-mediated behavior in olfactory bulbectomized mice. , 2013, Life Science.

[34]  I. Sora,et al.  Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. , 2013, The international journal of neuropsychopharmacology.

[35]  D. Overstreet,et al.  The Flinders Sensitive Line Rat Model of Depression—25 Years and Still Producing , 2013, Pharmacological Reviews.

[36]  Aaron S. Andalman,et al.  Dopamine neurons modulate neural encoding and expression of depression-related behaviour , 2012, Nature.

[37]  B. Connor,et al.  Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress , 2012, Neuropharmacology.

[38]  K. Deisseroth,et al.  A prefrontal cortex–brainstem neuronal projection that controls response to behavioural challenge , 2012, Nature.

[39]  P. Celada,et al.  Preclinical and clinical characterization of the selective 5‐HT1A receptor antagonist DU‐125530 for antidepressant treatment , 2012, British journal of pharmacology.

[40]  Qin Wang,et al.  α2 adrenergic receptor dysregulation in depressive disorders: Implications for the neurobiology of depression and antidepressant therapy , 2012, Neuroscience & Biobehavioral Reviews.

[41]  A. Rodrigues,et al.  Antidepressant-like effect of creatine in mice involves dopaminergic activation , 2012, Journal of psychopharmacology.

[42]  Xiaohua Li,et al.  Noradrenergic antidepressant responses to desipramine in vivo are reciprocally regulated by arrestin3 and spinophilin , 2012, Neuropharmacology.

[43]  C. Girish,et al.  Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. , 2012, European journal of pharmacology.

[44]  Yan-Jun Liu,et al.  Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocallis citrina. , 2012, Journal of ethnopharmacology.

[45]  L. Hein,et al.  Are the pharmacology and physiology of α2adrenoceptors determined by α2‐heteroreceptors and autoreceptors respectively? , 2012, British journal of pharmacology.

[46]  Alice M Stamatakis,et al.  Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking. , 2011, Nature.

[47]  R. Gainetdinov,et al.  The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.

[48]  I. Lucki,et al.  The role of serotonin receptor subtypes in treating depression: a review of animal studies , 2011, Psychopharmacology.

[49]  Philip L De Jager,et al.  Parkinson's disease: genetics and pathogenesis. , 2011, Annual review of pathology.

[50]  H. Anisman,et al.  Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects , 2010, Nature Medicine.

[51]  A. Rodrigues,et al.  Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test. , 2010, European journal of pharmacology.

[52]  G. Knudsen,et al.  Changes in 5-HT4 receptor and 5-HT transporter binding in olfactory bulbectomized and glucocorticoid receptor heterozygous mice , 2010, Neurochemistry International.

[53]  J. Docherty.  Subtypes of functional α1-adrenoceptor , 2010, Cellular and Molecular Life Sciences.

[54]  V. Doze,et al.  α1A- and α1B-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse , 2009, Brain Research.

[55]  R. Oosting,et al.  Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats. , 2009, European journal of pharmacology.

[56]  L. Cervo,et al.  Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice. , 2009, The international journal of neuropsychopharmacology.

[57]  D. Overstreet,et al.  The brain 5‐HT4 receptor binding is down‐regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration , 2009, Journal of neurochemistry.

[58]  K. Deisseroth,et al.  Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning , 2009, Science.

[59]  M. Diksic,et al.  A genetic rat model of depression, Flinders sensitive line, has a lower density of 5-HT1A receptors, but a higher density of 5-HT1B receptors, compared to control rats , 2009, Neurochemistry International.

[60]  S. Sara.  The locus coeruleus and noradrenergic modulation of cognition , 2009, Nature Reviews Neuroscience.

[61]  M. Geyer,et al.  5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice , 2009, Neuropsychopharmacology.

[62]  C. Repérant,et al.  Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review , 2009, Fundamental & clinical pharmacology.

[63]  M. Vogt,et al.  Dopamine receptor 3 (D3) knockout mice show regular emotional behaviour. , 2008, Pharmacological research.

[64]  P. Davies,et al.  3B but which 3B and that's just one of the questions: the heterogeneity of human 5-HT3 receptors. , 2008, Trends in pharmacological sciences.

[65]  D. Overstreet,et al.  Confirmation of antidepressant potential of the selective β3 adrenoceptor agonist amibegron in an animal model of depression , 2008, Pharmacology Biochemistry and Behavior.

[66]  Juha Markkula,et al.  Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. , 2008, The international journal of neuropsychopharmacology.

[67]  E. Jutkiewicz,et al.  Dopamine D2/D3 receptor agonists produce antidepressant‐like effects in the rat forced swim test through co‐activation of both receptor subtypes , 2008 .

[68]  R. Hickling,et al.  Pharmacology and Metabolism of Renzapride , 2008, Drugs in R&D.

[69]  A. Meneses,et al.  Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: Short- and long-term memory , 2007, Behavioural Brain Research.

[70]  K. Deisseroth,et al.  Neural substrates of awakening probed with optogenetic control of hypocretin neurons , 2007, Nature.

[71]  M. Kuśmider,et al.  Effect of citalopram in the modified forced swim test in rats. , 2007, Pharmacological reports : PR.

[72]  Abbas F. Sadikot,et al.  Serotonin4 (5-HT4) Receptor Agonists Are Putative Antidepressants with a Rapid Onset of Action , 2007, Neuron.

[73]  A. Wesołowska,et al.  Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats , 2007, Behavioural pharmacology.

[74]  A. Bjørnebekk,et al.  Isolated Flinders Sensitive Line rats have decreased dopamine D2 receptor mRNA , 2007, Neuroreport.

[75]  A. Wesołowska,et al.  Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression , 2007, Neuropharmacology.

[76]  I. Lucki,et al.  Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents , 2007, Psychopharmacology.

[77]  R. Hellweg,et al.  Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas , 2007, Neurobiology of Disease.

[78]  R. Hen,et al.  Adaptive changes in serotonin neurons of the raphe nuclei in 5‐HT4 receptor knock‐out mouse , 2006, European Journal of Neuroscience.

[79]  P. Simpson,et al.  Localization of the mouse α1A‐adrenergic receptor (AR) in the brain: α1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors , 2006 .

[80]  E. Leinonen,et al.  A review of the pharmacological and clinical profile of mirtazapine. , 2006, CNS drug reviews.

[81]  J. Hagan,et al.  Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidep , 2006, Neuropharmacology.

[82]  M. Millan.  Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. , 2006, Pharmacology & therapeutics.

[83]  Bryan L Roth,et al.  Evidence for the Preferential Involvement of 5-HT2A Serotonin Receptors in Stress- and Drug-Induced Dopamine Release in the Rat Medial Prefrontal Cortex , 2006, Neuropsychopharmacology.

[84]  I. Lucki,et al.  Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test , 2005, Neuroscience & Biobehavioral Reviews.

[85]  J. Cryan,et al.  The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice , 2005, Neuroscience & Biobehavioral Reviews.

[86]  D. Popa,et al.  Contribution of 5-HT2 Receptor Subtypes to Sleep–Wakefulness and Respiratory Control, and Functional Adaptations in Knock-Out Mice Lacking 5-HT2A Receptors , 2005, The Journal of Neuroscience.

[87]  I. Lucki,et al.  Sex Differences in the Regulation of Serotonergic Transmission and Behavior in 5-HT Receptor Knockout Mice , 2005, Neuropsychopharmacology.

[88]  P. Whiting,et al.  Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression , 2005, Neuropharmacology.

[89]  D. Overstreet,et al.  Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment , 2005, Neuropharmacology.

[90]  S. Bhatnagar,et al.  Deletion of the 5-HT3 receptor differentially affects behavior of males and females in the Porsolt forced swim and defensive withdrawal tests , 2004, Behavioural Brain Research.

[91]  C. Halldin,et al.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.

[92]  J. Cryan,et al.  Genetic and Pharmacological Evidence of a Role for GABAB Receptors in the Modulation of Anxiety- and Antidepressant-Like Behavior , 2004, Neuropsychopharmacology.

[93]  A. S. Elhwuegi.  Central monoamines and their role in major depression , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[94]  G. Bartoszyk,et al.  The highly selective 5‐hydroxytryptamine (5‐HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test , 2004, Synapse.

[95]  E. Tatarczyńska,et al.  Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test. , 2004, European journal of pharmacology.

[96]  M. Bourin,et al.  Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. , 2004, Journal of psychiatry & neuroscience : JPN.

[97]  A. Fox.  Onset of Effect of 5‐HT1B/1D Agonists: A Model With Pharmacokinetic Validation , 2004, Headache.

[98]  Y. Hacımusalar,et al.  Neurobiology of suicidal behaviour , 2003, Nature Reviews Neuroscience.

[99]  C. Stockmeier.  Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. , 2003, Journal of psychiatric research.

[100]  A. Deutch,et al.  The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats , 2003, Neuroscience Letters.

[101]  J. O'Donnell,et al.  Antagonism of the antidepressant-like effects of clenbuterol by central administration of β-adrenergic antagonists in rats , 2003, Psychopharmacology.

[102]  Gozoh Tsujimoto,et al.  Recent advances in α1-adrenoceptor pharmacology , 2003 .

[103]  C. McDougle,et al.  Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders , 2003, Neuropsychopharmacology.

[104]  Victoria Arango,et al.  Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 , 2002, Brain Research.

[105]  V. Klimek,et al.  Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study , 2002, Biological Psychiatry.

[106]  P. Rocca,et al.  Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[107]  Jun Li,et al.  [Association of 5-HT(2A) receptor polymorphism and attention deficit hyperactivity disorder in children]. , 2002, Zhonghua yi xue za zhi.

[108]  Victoria Arango,et al.  Serotonin 1A Receptors, Serotonin Transporter Binding and Serotonin Transporter mRNA Expression in the Brainstem of Depressed Suicide Victims , 2001, Neuropsychopharmacology.

[109]  M. Oquendo,et al.  Prolactin Response to dl-Fenfluramine Challenge before and after Treatment with Paroxetine , 2001, Neuropsychopharmacology.

[110]  V. Klimek,et al.  Noradrenergic Pathology in Psychiatric Disorders: Postmortem Studies , 2001, CNS Spectrums.

[111]  M. P. McDonald,et al.  The α2A-Adrenergic Receptor Plays a Protective Role in Mouse Behavioral Models of Depression and Anxiety , 2001, The Journal of Neuroscience.

[112]  A. Heinz,et al.  Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence. , 2001, Pharmacopsychiatry.

[113]  I. Lucki,et al.  Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. , 2000, The Journal of pharmacology and experimental therapeutics.

[114]  D. Overstreet,et al.  The flinders sensitive line rats, a genetic model of depression, show abnormal serotonin receptor mRNA expression in the brain that is reversed by 17beta-estradiol. , 1999, Brain research. Molecular brain research.

[115]  H. Akil,et al.  Expression of α1b Adrenoceptor mRNA in Corticotropin-Releasing Hormone-Containing Cells of the Rat Hypothalamus and Its Regulation by Corticosterone , 1999, The Journal of Neuroscience.

[116]  B. Kobilka,et al.  Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission , 1999, Nature.

[117]  P. Blier,et al.  Autoregulation of serotonin neurons: role in antidepressant drug action. , 1999, Pharmacological reviews.

[118]  E. Azmitia.  Serotonin Neurons, Neuroplasticity, and Homeostasis of Neural Tissue , 1999, Neuropsychopharmacology.

[119]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[120]  L H Parsons,et al.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[121]  R Hen,et al.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[122]  M Toth,et al.  Increased anxiety of mice lacking the serotonin1A receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Y. Nakagawa,et al.  The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats , 1998, Brain Research.

[124]  P. Willner.  Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation , 1997, Psychopharmacology.

[125]  C. Katona,et al.  Brain α-adrenoceptors in depressed suicides , 1997, Brain Research.

[126]  J. Kelly,et al.  The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat , 1997, European Neuropsychopharmacology.

[127]  C. Katona,et al.  Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls , 1997, Brain Research.

[128]  J. Gaddum,et al.  TWO KINDS OF TRYPTAMINE RECEPTOR , 1997, British journal of pharmacology and chemotherapy.

[129]  J. Mann,et al.  Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients , 1997, Biological Psychiatry.

[130]  C. Montigny,et al.  Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists , 1996, Trends in Neurosciences.

[131]  J. Neumaier,et al.  Chronic Fluoxetine Reduces Serotonin Transporter mRNA and 5-HT1B mRNA in a Sequential Manner in the Rat Dorsal Raphe Nucleus , 1996, Neuropsychopharmacology.

[132]  R. Fremeau,et al.  EXPRESSION OF α2-ADRENERGIC RECEPTOR SUBTYPES IN THE MOUSE BRAIN: EVALUATION OF SPATIAL AND TEMPORAL INFORMATION IMPARTED BY 3 kb OF 5′ REGULATORY SEQUENCE FOR THE α2A AR-RECEPTOR GENE IN TRANSGENIC ANIMALS , 1996, Neuroscience.

[133]  M. Papp,et al.  The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression , 1995, Neuropharmacology.

[134]  Michael Rickels,et al.  Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants , 1995, Psychopharmacology.

[135]  F. Borsini,et al.  Role of the serotonergic system in the forced swimming test , 1995, Neuroscience & Biobehavioral Reviews.

[136]  R. Lefkowitz,et al.  International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. , 1995, Pharmacological reviews.

[137]  P. Ferrara,et al.  Evidence for the presence of β3-adrenergic receptor mRNA in the human brain , 1995 .

[138]  R Hen,et al.  Enhanced aggressive behavior in mice lacking 5-HT1B receptor. , 1994, Science.

[139]  P. D’Aquila,et al.  Antidepressant-like effect of selective dopamine D1 receptor agonists in the behavioural despair animal model of depression. , 1994, European journal of pharmacology.

[140]  G. Andersson,et al.  Preclinical pharmacology of FG5893: a potential anxiolytic drug with high affinity for both 5-HT1A and 5-HT2A receptors. , 1994, European journal of pharmacology.

[141]  M. Pompeiano,et al.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.

[142]  V. Arango,et al.  Quantitative autoradiography of α 1- and α 2-adrenergic receptors in the cerebral cortex of controls and suicide victims , 1993, Brain Research.

[143]  T. Hökfelt,et al.  Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: An in situ hybridization study , 1993, Neuroscience.

[144]  I. Lucki,et al.  Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors , 1993, Neuropharmacology.

[145]  D. Sibley,et al.  Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. , 1993, Molecular pharmacology.

[146]  G. Skuza,et al.  Effects of MK-801 and antidepressant drugs in the forced swimming test in rats , 1992, European Neuropsychopharmacology.

[147]  J. García-Sevilla,et al.  α 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression , 1992, Biological Psychiatry.

[148]  Anat Biegon,et al.  Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem: effects of age and alcohol , 1991, Brain Research.

[149]  C. Katona,et al.  Brain β-adrenoceptor binding sites in antidepressant-free depressed suicide victims , 1990, Brain Research.

[150]  V. Arango,et al.  Evidence for the 5-HT Hypothesis of Suicide A Review of Post-mortem Studies , 1989, British Journal of Psychiatry.

[151]  L. Cervo,et al.  1-(3-Trifluoromethylphenyl) piperazine (TFMPP) in the ventral tegmental area reduces the effect of desipramine in the forced swimming test in rats: possible role of serotonin receptors. , 1989, European journal of pharmacology.

[152]  L. Siever,et al.  Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. , 1989, Archives of general psychiatry.

[153]  M. Caron,et al.  The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor , 1988, Nature.

[154]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[155]  J. Glowinski,et al.  Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.

[156]  R. Pinder,et al.  The potential therapeutic role of the enantiomers and metabolites of mianserin. , 1983, British journal of clinical pharmacology.

[157]  R. Porsolt,et al.  Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. , 1979, European journal of pharmacology.

[158]  R. Porsolt,et al.  Behavioural despair in rats: a new model sensitive to antidepressant treatments. , 1978, European journal of pharmacology.

[159]  R. Porsolt,et al.  Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.

[160]  M. Åsberg,et al.  5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? , 1976, Archives of general psychiatry.

[161]  J. Schildkraut,et al.  The catecholamine hypothesis of affective disorders: a review of supporting evidence. , 1965, The American journal of psychiatry.

[162]  Qin Wang,et al.  α2 Adrenergic Receptor Trafficking as a Therapeutic Target in Antidepressant Drug Action. , 2015, Progress in molecular biology and translational science.

[163]  D. Slattery,et al.  The ups and downs of modelling mood disorders in rodents. , 2014, ILAR journal.

[164]  D. Overstreet.  Modeling depression in animal models. , 2012, Methods in molecular biology.

[165]  G. Koob,et al.  Animal models of psychiatric disorders. , 2012, Handbook of clinical neurology.

[166]  A. Grace,et al.  The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. , 2007, International review of neurobiology.

[167]  J. García-Sevilla,et al.  Increasedα 2;-adrenoceptor density in the frontal cortex of depressed suicide victims , 2005, Journal of Neural Transmission.

[168]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[169]  Michel Bourin,et al.  Forced swimming test in mice: a review of antidepressant activity , 2004, Psychopharmacology.

[170]  J. Adrien.  [Implication of serotonin in the control of vigilance states as revealed by knockout-mouse studies]. , 2004, Journal de la Societe de biologie.

[171]  J. Adrien.  L'implication de la sérotonine dans le contrôle des états de vigilance revisitée par l'étude de souris invalidées : Implications physiologiques et physiopathologiques de la sérotonine : nouvelles données chez les souris K0 , 2004 .

[172]  C. Halldin,et al.  Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[173]  R. Hen,et al.  [Homozygote mice deficient in serotonin 5-HT1B receptor and antidepressant effect of selective serotonin reuptake inhibitors]. , 1998, Comptes rendus des seances de la Societe de biologie et de ses filiales.

[174]  T. Shimazoe,et al.  [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor]. , 1989, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[175]  J. Maj,et al.  Action of serotoninmimetics in the behavioral despair test in rats. , 1979, Communications in psychopharmacology.